PRESS RELEASE published on 07/23/2026 at 22:05, 1 month 28 days ago Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés. L'équipe de direction d'Abivax s'agrandit pour préparer le lancement potentiel d'obéfazimod aux États-Unis Abivax Obefazimod Commercialisation États-Unis Nominations Stratégiques
PRESS RELEASE published on 07/23/2026 at 22:05, 1 month 28 days ago Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments Abivax strengthens commercial capabilities with strategic leadership appointments, preparing for potential U.S. commercialization of obefazimod. Abivax expands Commercial Leadership Team with industry leaders Abivax Obefazimod Leadership Appointments U.S. Commercialization Commercial Capabilities
BRIEF published on 07/17/2026 at 18:05, 2 months 4 days ago Update of ABIVAX's share capital and voting rights Share Capital Voting Rights Biotechnology Actions Abivax
BRIEF published on 07/17/2026 at 18:05, 2 months 4 days ago Mise à jour du capital social et des droits de vote d'ABIVAX Droits De Vote Capital Social Biotechnologie Actions Abivax
PRESS RELEASE published on 07/17/2026 at 18:00, 2 months 4 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.06.26 ABIVAX publie les nombres d'actions et de droits de vote au 30/06/26 conformément aux réglementations AMF. La société se concentre sur le développement de traitements pour les maladies inflammatoires Droits De Vote Actions Abivax Réglementation Traitements
BRIEF published on 07/06/2026 at 22:10, 2 months 14 days ago Abivax Completes its $920 Million Public Offering Biotechnology Actions Funding Abivax Public Offering
BRIEF published on 07/06/2026 at 22:10, 2 months 14 days ago Abivax Achève son Offre Publique de 920 Millions de Dollars Biotechnologie Actions Financement Abivax Offre Publique
BRIEF published on 07/06/2026 at 22:10, 2 months 14 days ago Abivax lève 920 millions de dollars lors d'une offre publique Biotechnologie Abivax Rectocolite Hémorragique Offre Publique Actions De Dépôt Américaines
BRIEF published on 07/06/2026 at 22:10, 2 months 14 days ago Abivax Secures $920 Million in Public Offering Biotechnology Abivax Ulcerative Colitis Public Offering American Depositary Shares
PRESS RELEASE published on 07/06/2026 at 22:05, 2 months 14 days ago Abivax annonce la réalisation de son offre au public de 920 millions de dollars Abivax réalise son offre publique de 920 millions de dollars pour le développement de thérapies biotechnologiques. Les actions sont cotées sur Euronext Paris et le Nasdaq Biotechnologie Abivax Offre Publique Thérapies Cotées
Published on 09/21/2026 at 15:45, 4 hours 30 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 5 hours 55 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 6 hours 10 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 6 hours 15 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 6 hours 30 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 19:00, 1 hour 15 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026
Published on 09/21/2026 at 18:00, 2 hours 15 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 2 hours 30 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 2 hours 30 minutes ago Charwood Energy poursuit sur un rythme de croissance élevé. Chiffre d’affaires semestriel en hausse de +43 % à 5,6 M€.
Published on 09/21/2026 at 17:45, 2 hours 30 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 18:19, 1 hour 56 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 1 hour 56 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 2 hours 14 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 2 hours 29 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 2 hours 29 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026